Skip to content
Ecat.nl
Ecat.nl
Home
Docs
Parameter
Laboratory Tests
ReoRox G2
ReoRox G2
Related items
Analytical Information :
7
Pre-Analytical Issues in Platelet Function Testing - An Update
Minimum citrate tube fill volume for routine coagulation testing
Pre-Analytical Issues in Platelet Function Testing - An Update
Update on platelet aggregation testing
Comparison of two statistical software programs for determining reference intervals of screening coagulation assays
Analytical performance specifications for hemostasis parameters
The effect of Rivaroxaban on haemostasis assays; results from ECAT surveys
Cases :
8
Prekallikrein deficiency
Effect of high haematocrit levels on coagulation testing
A patient with mild haemophilia A
Hermansky-Pudlak syndrome
Lupus Anticoagulant-Hypoprothrombinemia Syndrome
Hermansky Pudlak syndrome
Acquired Glanzmann’s thrombasthenia
Dysfibrinogenemia, case study
Guidelines :
3
ICSH recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests
Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies
Recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders, ICSH recommendations
Haemostatic Cascade :
5
TF Pathway (Extrinsic) with Common Pathway (PT)
Intrinsic Pathway APTT
Fibrinolytic Pathway
Coagulation Pathways (All Components)
Activation of TAFI by Thrombin
Quality Issues :
3
Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications
Wet Workshop on Platelet Function Testing
External quality assessment / proficiency testing for platelet function disorders
Surveys and Studies :
1
Emicizumab pilot study, part II
Questions or suggestions?
Clotpedia Support Form
Submit
Success
